Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1890 2
1953 1
1954 1
1982 1
2001 1
2003 2
2004 5
2005 7
2006 8
2007 10
2008 14
2009 15
2010 10
2011 9
2012 11
2013 8
2014 5
2015 5
2016 3
2017 7
2018 9
2019 12
2020 15
2021 16
2022 27
2023 21
2024 11
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.
van Vollenhoven RF, Fleischmann R, Cohen S, Lee EB, García Meijide JA, Wagner S, Forejtova S, Zwillich SH, Gruben D, Koncz T, Wallenstein GV, Krishnaswami S, Bradley JD, Wilkinson B; ORAL Standard Investigators. van Vollenhoven RF, et al. N Engl J Med. 2012 Aug 9;367(6):508-19. doi: 10.1056/NEJMoa1112072. N Engl J Med. 2012. PMID: 22873531 Free article. Clinical Trial.
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
Fleischmann R, Mysler E, Hall S, Kivitz AJ, Moots RJ, Luo Z, DeMasi R, Soma K, Zhang R, Takiya L, Tatulych S, Mojcik C, Krishnaswami S, Menon S, Smolen JS; ORAL Strategy investigators. Fleischmann R, et al. Lancet. 2017 Jul 29;390(10093):457-468. doi: 10.1016/S0140-6736(17)31618-5. Epub 2017 Jun 16. Lancet. 2017. PMID: 28629665 Clinical Trial.
A synthesis of evidence for policy from behavioural science during COVID-19.
Ruggeri K, Stock F, Haslam SA, Capraro V, Boggio P, Ellemers N, Cichocka A, Douglas KM, Rand DG, van der Linden S, Cikara M, Finkel EJ, Druckman JN, Wohl MJA, Petty RE, Tucker JA, Shariff A, Gelfand M, Packer D, Jetten J, Van Lange PAM, Pennycook G, Peters E, Baicker K, Crum A, Weeden KA, Napper L, Tabri N, Zaki J, Skitka L, Kitayama S, Mobbs D, Sunstein CR, Ashcroft-Jones S, Todsen AL, Hajian A, Verra S, Buehler V, Friedemann M, Hecht M, Mobarak RS, Karakasheva R, Tünte MR, Yeung SK, Rosenbaum RS, Lep Ž, Yamada Y, Hudson STJ, Macchia L, Soboleva I, Dimant E, Geiger SJ, Jarke H, Wingen T, Berkessel JB, Mareva S, McGill L, Papa F, Većkalov B, Afif Z, Buabang EK, Landman M, Tavera F, Andrews JL, Bursalıoğlu A, Zupan Z, Wagner L, Navajas J, Vranka M, Kasdan D, Chen P, Hudson KR, Novak LM, Teas P, Rachev NR, Galizzi MM, Milkman KL, Petrović M, Van Bavel JJ, Willer R. Ruggeri K, et al. Among authors: douglas km. Nature. 2024 Jan;625(7993):134-147. doi: 10.1038/s41586-023-06840-9. Epub 2023 Dec 13. Nature. 2024. PMID: 38093007 Free PMC article.
Are Conspiracy Theories Harmless?
Douglas KM. Douglas KM. Span J Psychol. 2021 Feb 22;24:e13. doi: 10.1017/SJP.2021.10. Span J Psychol. 2021. PMID: 33612140
Missed opportunities for treatment of inflammatory arthritis and factors associated with non-treatment: An observational cohort study in United States Veterans with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
Walsh JA, Pei S, Alexander S, Braaten T, Walker JH, Clewell J, Douglas KM, Penmetsa GK, Ye X, Breviu B, Cannon GW, Kunkel GA, Sauer BC. Walsh JA, et al. Among authors: douglas km. Semin Arthritis Rheum. 2024 Jun;66:152436. doi: 10.1016/j.semarthrit.2024.152436. Epub 2024 Mar 28. Semin Arthritis Rheum. 2024. PMID: 38714073
Inflammation and atherosclerosis in rheumatoid arthritis.
Stevens RJ, Douglas KM, Saratzis AN, Kitas GD. Stevens RJ, et al. Among authors: douglas km. Expert Rev Mol Med. 2005 May 6;7(7):1-24. doi: 10.1017/S1462399405009154. Expert Rev Mol Med. 2005. PMID: 15876361 Review.
Psychological therapies for people with bipolar disorder: Where are we now, and what is next? ISBD Psychological Interventions Taskforce-Position paper.
Wright K, Koenders M, Douglas KM, Faurholt-Jepsen M, Lewandowski KE, Miklowitz DJ, Morton E, Murray G, Richardson T, de Siqueira Rotenberg L, Sperry SH, Van Meter AR, Vassilev AB, Weiner L, Weinstock LM, Mesman E. Wright K, et al. Among authors: douglas km. Bipolar Disord. 2024 Sep;26(6):523-528. doi: 10.1111/bdi.13418. Epub 2024 Apr 17. Bipolar Disord. 2024. PMID: 38632696 No abstract available.
Supporting career development for early- and mid-career professionals working in the bipolar disorder field: Key initiatives to be implemented by the International Society for Bipolar Disorders Early- and Mid-Career Committee.
Douglas KM, Sperry SH, Dean OM, Fries GR, Gomes FA, Pavón JJ, Morton E, Mitchell RHB, Van Rheenen TE, Verdolini N, Xu N, Hosang GM, Huber RS. Douglas KM, et al. Bipolar Disord. 2024 May;26(3):211-215. doi: 10.1111/bdi.13416. Epub 2024 Apr 15. Bipolar Disord. 2024. PMID: 38622803 No abstract available.
190 results